Covered recipient · General Payments record
ELIZABETH CHRISTIAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,015.31
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.67 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $86.73 | 4 |
| Lilly USA, LLC | $60.79 | 3 |
| Phadia US Inc. | $37.62 | 2 |
| Novo Nordisk AS | $32.87 | 2 |
| Acerta Pharma LLC | $28.27 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.93 | 1 |
| Astellas Pharma US Inc | $17.01 | 1 |
| Amgen Inc. | $15.77 | 1 |
| Organon LLC | $6.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.24 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124863032 | CMS |
| Abbott Laboratories | $22.00 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124863034 | CMS |
| Abbott Laboratories | $20.37 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124863036 | CMS |
| Abbott Laboratories | $23.12 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124863038 | CMS |
| Amgen Inc. | $15.77 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117527107 | CMS |
| Astellas Pharma US Inc | $17.01 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139526238 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.27 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104615534 | CMS |
| Lilly USA, LLC | $20.54 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135618999 | CMS |
| Lilly USA, LLC | $19.19 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135619001 | CMS |
| Lilly USA, LLC | $21.06 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135550663 | CMS |
| Novo Nordisk Inc | $15.16 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100565820 | CMS |
| Novo Nordisk Inc | $17.71 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100294004 | CMS |
| Organon Llc | $6.68 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136229444 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.93 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119044898 | CMS |
| Phadia US Inc. | $16.05 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578354 | CMS |
| Phadia US Inc. | $21.57 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578356 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.